Zobrazeno 1 - 10
of 207
pro vyhledávání: '"Toshio Kubo"'
Autor:
Tatsunori Shimoi, Kuniko Sunami, Makoto Tahara, Satoshi Nishiwaki, Shota Tanaka, Eishi Baba, Masashi Kanai, Ichiro Kinoshita, Hidekazu Shirota, Hideyuki Hayashi, Naohiro Nishida, Toshio Kubo, Nobuaki Mamesaya, Yayoi Ando, Natsuko Okita, Taro Shibata, Kenichi Nakamura, Noboru Yamamoto
Publikováno v:
EClinicalMedicine, Vol 69, Iss , Pp 102447- (2024)
Summary: Background: BRAF V600 mutations are common in melanoma, thyroid, and non-small-cell lung cancers. Despite dabrafenib and trametinib being standard treatments for certain cancers, their efficacy across various solid tumours remains unelucidat
Externí odkaz:
https://doaj.org/article/e4b60dfa03624d70ba3fcc3329c90c50
Autor:
Daijiro Harada, Tomoki Tamura, Kiichiro Ninomiya, Toshio Kubo, Shoichi Kuyama, Sayaka Tachibana, Koji Inoue, Kenichi Chikamori, Kenichiro Kudo, Nobuaki Ochi, Yoshinobu Maeda, Katsuyuki Kiura
Publikováno v:
Thoracic Cancer, Vol 14, Iss 3, Pp 231-236 (2023)
Abstract Background COVID‐19 incidence is high in patients with cancer. The fatality rate was high for the Delta variant, necessitating infection prevention by vaccination. This study evaluated the safety of a SARS‐CoV‐2 vaccine in patients wit
Externí odkaz:
https://doaj.org/article/97bb7b8b8c774c5ea9342c7b835db576
Autor:
Jun Takata, Naoko Miyake, Yusuke Saiki, Misako Tada, Kensuke Sasaki, Toshio Kubo, Katsuyuki Kiura, Sakae Arimoto-Kobayashi
Publikováno v:
Genes and Environment, Vol 44, Iss 1, Pp 1-10 (2022)
Abstract Background Previously, we reported the inhibitory effect of Actinidia arguta juice, known as sarunashi juice (sar-j) in Japan, on mutagenesis, inflammation, and mouse skin tumorigenesis. The components of A. arguta responsible for the anti-m
Externí odkaz:
https://doaj.org/article/9ece874efbff42f59810ab8eb75ba1d2
Autor:
Go Makimoto, Atsushi Shimonishi, Kadoaki Ohashi, Kiichiro Ninomiya, Hisao Higo, Yuka Kato, Masanori Fujii, Toshio Kubo, Eiki Ichihara, Katsuyuki Hotta, Masahiro Tabata, Yoshinobu Maeda, Katsuyuki Kiura
Publikováno v:
Case Reports in Oncology, Vol 15, Iss 2, Pp 494-498 (2022)
Tepotinib, the novel MET-tyrosine kinase inhibitor, shows an antitumor effect for patients with non-small-cell lung cancer (NSCLC) harboring MET exon 14 skipping mutation. In January 2022, the AmoyDx® Pan Lung Cancer polymerase chain reaction Panel
Externí odkaz:
https://doaj.org/article/bfc3bf256a774f06afe80a674b5a7557
Autor:
Tomoki Tamura, Kiichiro Ninomiya, Toshio Kubo, Shoichi Kuyama, Sayaka Tachibana, Koji Inoue, Kenichi Chikamori, Kenichiro Kudo, Nobuaki Ochi, Daijiro Harada, Yoshinobu Maeda, Katsuyuki Kiura
Publikováno v:
Thoracic Cancer, Vol 13, Iss 3, Pp 453-459 (2022)
Abstract Background Since 2020, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has become prevalent worldwide. In severe cases, the case fatality rate is high, and vaccine prevention is important. This study evaluated the safety of
Externí odkaz:
https://doaj.org/article/424ceb059e7e4c87aac9877f602b5941
Autor:
Hisao Higo, Kadoaki Ohashi, Shuta Tomida, Sachi Okawa, Hiromasa Yamamoto, Seiichiro Sugimoto, Satoru Senoo, Go Makimoto, Kiichiro Ninomiya, Takamasa Nakasuka, Kazuya Nishii, Akihiko Taniguchi, Toshio Kubo, Eiki Ichihara, Katsuyuki Hotta, Nobuaki Miyahara, Yoshinobu Maeda, Shinichi Toyooka, Katsuyuki Kiura
Publikováno v:
Respiratory Research, Vol 23, Iss 1, Pp 1-10 (2022)
Abstract Background Tyrosine kinase activation plays an important role in the progression of pulmonary fibrosis. In this study, we analyzed the expression of 612 kinase-coding and cancer-related genes using next-generation sequencing to identify pote
Externí odkaz:
https://doaj.org/article/0d4105daf2044a01bae3d734d4fb44a5
Publikováno v:
Journal of Cutaneous Immunology and Allergy, Vol 4, Iss 6, Pp 170-172 (2021)
We described a case of BP that developed 2.5 years after the administration of nivolumab for metastatic non‐small cell lung cancer. Our report highlights the fact that dermatologists should be aware of anti PD‐1‐related BP, which can appear ver
Externí odkaz:
https://doaj.org/article/c13686787fc34df6b290fef44c1c5e16
Autor:
Masataka Taoka, Go Makimoto, Noriyuki Umakoshi, Kiichiro Ninomiya, Hisao Higo, Yuka Kato, Masanori Fujii, Toshio Kubo, Eiki Ichihara, Kadoaki Ohashi, Katsuyuki Hotta, Masahiro Tabata, Yoshinobu Maeda, Katsuyuki Kiura
Publikováno v:
Respiratory Medicine Case Reports, Vol 38, Iss , Pp 101669- (2022)
A 76-year-old woman who was treated with lorlatinib for postoperative recurrent anaplastic lymphoma kinase-positive lung adenocarcinoma visited our hospital with massive hemoptysis. Chest computed tomography showed massive bleeding from the right upp
Externí odkaz:
https://doaj.org/article/f8430e62748f401d8a911c8358f80a68
Autor:
Katsuyuki Hotta, Yuka Kato, Natasha Leighl, Nagio Takigawa, Rabab Mohamed Gaafar, Hiroe Kayatani, Taizo Hirata, Kadoaki Ohashi, Toshio Kubo, Masahiro Tabata, Mitsune Tanimoto, Katsuyuki Kiura
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0121211 (2015)
BACKGROUND: In evaluation of the clinical benefit of a new targeted agent in a phase 3 trial enrolling molecularly selected patients with advanced non-small cell lung cancer (NSCLC), overall survival (OS) as an endpoint seems to be of limited use bec
Externí odkaz:
https://doaj.org/article/284a0d7b79d247f297344308e9ec838e
Autor:
Daijiro Harada, Tomoki Tamura, Kiichiro Ninomiya, Toshio Kubo, Shoichi Kuyama, Sayaka Tachibana, Koji Inoue, Kenichi Chikamori, Kenichiro Kudo, Nobuaki Ochi, Yoshinobu Maeda, Katsuyuki Kiura
Publikováno v:
Thoracic Cancer. 14:231-236